Professor Ernst Hafen is based at the Institute of Molecular Systems Biology at ETH Zurich. He studied the developmental and […]
Join us for Genomics in Drug Discovery ONLINE, a unique 3-part webinar series, where we explore the role of genetics […]
Christmas is over but the festivities have only just begun! So, grab your favourite cushion and a coffee because the […]
With drug discovery being an expensive process and genetic-based drugs being more likely to succeed, the level of investment in […]
The UKB-ESC research team has published a paper that explains how the collaboration between the UK Biobank and biopharmaceutical companies […]
Recently, researchers have developed a machine learning approach that can predict the fitness trajectories of cancer cells in response to […]
Despite an increase in investment into R&D from biopharma companies, only 5-10% of drugs that enter early-stage clinical trials ever […]
Clinical trials are used to determine the efficacy of a drug in patients. However, effective clinical trials that have a large […]
Epigenetic targets are of significant importance in drug discovery research, and there is increasing availability of chemogenomic data related to […]
A team of researchers have developed a personalized genomic medicine platform, My Personal Mutanome, that will help accelerate genome-informed cancer […]
